Regencell Bioscience Holdings Limited

NASDAQ:RGC

38.01 (USD) • At close June 20, 2025
Bedrijfsnaam Regencell Bioscience Holdings Limited
Symbool RGC
Munteenheid USD
Prijs 38.01
Beurswaarde 18,795,526,890
Dividendpercentage 0%
52-weken bereik 0.08 - 83.6
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Yat-Gai Au
Website https://www.regencellbioscience.com

An error occurred while fetching data.

Over Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway

Vergelijkbare Aandelen

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

60.48 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

63 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

1.07 USD

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

9.23 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

3.62 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

4.63 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

1.705 USD

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

3.43 USD

Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

MNMD

7.05 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)